Wednesday, May 13, 2020
COVID-19 | REMDESIVIR
More deaths in Covid-19 patients given remdesivir than placebo, 15% vs 13%
On April 29, 2020 Dr. Anthony Fauci, one of the leads on the coronavirus Task Force for the White House on Covid-19, said that there is “clearcut evidence” that Remdesivir works for Covid-19, and that it is now the new “standard of care.”
Here are the results of another study that questions whether this is true or not.
A randomized, placebo-controlled Chinese trial found that 15% of those with Covid-19 given remdesivir died versus 13% of those given a placebo.
In other words, people given remdesivir were more likely to die than those given a placebo.
Read the entire article | Email this article
QUICKLINKS AND VIEW OPITONS
QUOTE OF THE DAY
Books by Larry Hobbs available on Amazon
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.